Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Treasury Shares: 2023-2024

Historic Treasury Shares for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $21,172.

  • Zenas BioPharma's Treasury Shares was N/A to $525,350 in Q3 2025 from the same period last year, while for Sep 2025 it was $525,350, marking a year-over-year change of. This contributed to the annual value of $21,172 for FY2024, which is 22.16% down from last year.
  • Per Zenas BioPharma's latest filing, its Treasury Shares stood at $21,172 for FY2024, which was down 22.16% from $27,200 recorded in FY2023.
  • Over the past 5 years, Zenas BioPharma's Treasury Shares peaked at $27,200 during FY2023, and registered a low of $21,172 during FY2024.
  • For the 2-year period, Zenas BioPharma's Treasury Shares averaged around $24,186, with its median value being $24,186 (2023).
  • Data for Zenas BioPharma's Treasury Shares shows a maximum YoY dropped of 22.16% (in 2024) over the last 5 years.
  • Zenas BioPharma's Treasury Shares (Yearly) stood at $27,200 in 2023, then declined by 22.16% to $21,172 in 2024.